In brief

BMJ 2002; 325 doi: (Published 20 July 2002) Cite this as: BMJ 2002;325:120

Medicines safety body issues advice on HRT: In the light of recent US research, the Committee on Safety of Medicines has reiterated that hormone replacement therapy (HRT) is not recommended for the prevention of coronary heart disease. The risks (small increases in breast cancer, coronary heart disease, and stroke) and benefits (reductions in colorectal cancer and …

View Full Text

Log in

Log in through your institution


* For online subscription